Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
ASCO Foundation Raised $200,000 In Its First Year.
ASCO Selects Three Cities For Quality Of Care Study.
Early Detection Network Completes Initial Funding From NCI.
FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.
Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.
One Health Plan, Genzyme Agree On Genetic Testing.
ECOG To Cease Participation In Melanoma Vaccine Study.
Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.
Myriad Wins Patent For p10 Tumor Suppressor Gene.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
